ADC Therapeutics ADCT
NYSE ADCT
$1.07 -0.15 (-12.30%)
As of: Oct 1, 2026 · 3:59 PM EDT

ADC Therapeutics (ADCT) Non Operating Income (2021 - 2026)

Updated

ADC Therapeutics' Non Operating Income was $8.85 million in Q2 2026, compared with -$11.25 million a year earlier.

Analysis

ADC Therapeutics (ADCT) Non Operating Income (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, ADC Therapeutics' Non Operating Income was -$20.12 million through Jun 30, 2026.

  • The Q2 2026 figure marks the highest quarterly Non Operating Income since Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 ADC Therapeutics 152.93 Mn -793.27 Mn 16.90 Mn 8.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.85 Mn
Mar 31, 2026 -7.72 Mn
Sep 30, 2025 -10.00 Mn
Jun 30, 2025 -11.25 Mn
Mar 31, 2025 -9.97 Mn
Sep 30, 2024 -8.06 Mn
Jun 30, 2024 -6.67 Mn
Mar 31, 2024 -12.14 Mn
Sep 30, 2023 -9.25 Mn
Jun 30, 2023 -13.00 Mn
Mar 31, 2023 -3,000.00
Sep 30, 2022 -37.12 Mn
Jun 30, 2022 12.88 Mn
Mar 31, 2022 13.44 Mn
Sep 30, 2021 -9.36 Mn
Jun 30, 2021 693,000.00
Mar 31, 2021 21.23 Mn
API Access

ADC Therapeutics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=ADCT&period=max&api_key=YOUR_API_KEY